Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sarah E. Kolitz
Observed names:
S. E. Kolitz,
S. Kolitz,
S.E. Kolitz,
Sarah Kolitz
Institution:
Immuneering (United States)
Observed institutions:
Johns Hopkins University,
Johns Hopkins Medicine,
Immuneering (United States),
Massachusetts Institute of Technology
ORCID:
0009-0007-7596-6765
Observed ORCID:
0009-0007-7596-6765
OpenAlex ID:
A5059021503
Reconstitution of Yeast Translation Initiation
2007
·
Michael G. Acker
, Sarah E. Kolitz
, et al.
·
Methods in enzymology on CD-ROM/Methods in enzymology
·
158
Initiation of Protein Synthesis by Hepatitis C Virus Is Refractory to Reduced eIF2 · GTP · Met-tRNA i Met Ternary Complex Availability
2006
·
Francis Robert
, Lee D. Kapp
, et al.
·
Molecular Biology of the Cell
·
125
Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19)
2020
·
Jason Kim
, Jenny Zhang
, et al.
·
Journal of Translational Medicine
·
106
PDF
Microfluidic probe for single-cell analysis in adherent tissue culture
2014
·
Aniruddh Sarkar
, Sarah Kolitz
, et al.
·
Nature Communications
·
98
PDF
Kinetic and thermodynamic analysis of the role of start codon/anticodon base pairing during eukaryotic translation initiation
2008
·
Sarah E. Kolitz
, Julie E. Takacs
, et al.
·
RNA
·
91
PDF
Pridopidine activates neuroprotective pathways impaired in Huntington Disease
2016
·
Michal Geva
, Rebecca Kusko
, et al.
·
Human Molecular Genetics
·
83
PDF
Eukaryotic initiator tRNA: Finely tuned and ready for action
2009
·
Sarah E. Kolitz
, Jon R. Lorsch
·
FEBS Letters
·
70
PDF
Detecting Kinase Activities from Single Cell Lysate Using Concentration-Enhanced Mobility Shift Assay
2014
·
Lih Feng Cheow
, Aniruddh Sarkar
, et al.
·
Analytical Chemistry
·
48
PDF
Yeast initiator tRNA identity elements cooperate to influence multiple steps of translation initiation
2006
·
Lee D. Kapp
, Sarah E. Kolitz
, et al.
·
RNA
·
41
PDF
Pharmacogenomics strategies to optimize treatments for multiple sclerosis: Insights from clinical research
2016
·
Iris Grossman
, Volker Knappertz
, et al.
·
Progress in Neurobiology
·
34
Measurement and Modeling of Signaling at the Single-Cell Level
2012
·
Sarah E. Kolitz
, Douglas A. Lauffenburger
·
Biochemistry
·
33
Conserved residues in yeast initiator tRNA calibrate initiation accuracy by regulating preinitiation complex stability at the start codon
2014
·
Jinsheng Dong
, Antonio Munoz
, et al.
·
Genes & Development
·
30
PDF
Functional effects of the antigen glatiramer acetate are complex and tightly associated with its composition
2015
·
Tal Hasson
, Sarah Kolitz
, et al.
·
Journal of Neuroimmunology
·
23
Physicochemical, biological, functional and toxicological characterization of the European follow-on glatiramer acetate product as compared with Copaxone
2018
·
S. Melamed-Gal
, P. Loupe
, et al.
·
eNeurologicalSci
·
22
PDF
Leveraging existing data sets to generate new insights into Alzheimer’s disease biology in specific patient subsets
2015
·
Kevin D. Fowler
, Jason M. Funt
, et al.
·
Scientific Reports
·
19
PDF
Gene expression studies of a human monocyte cell line identify dissimilarities between differently manufactured glatiramoids
2015
·
Sarah Kolitz
, Tal Hasson
, et al.
·
Scientific Reports
·
19
PDF
Compositional differences between Copaxone and Glatopa are reflected in altered immunomodulation ex vivo in a mouse model
2017
·
Iris Grossman
, Sarah Kolitz
, et al.
·
Annals of the New York Academy of Sciences
·
8
PDF
1524P Preliminary phase I safety and activity of IMM-1-104, an orally dosed universal RAS inhibitor that drives deep cyclic inhibition of the MAPK pathway at MEK, in patients with advanced unresectable or metastatic solid tumors
2024
·
V. Chung
, A.I. Spira
, et al.
·
Annals of Oncology
·
5
PDF
477 Deep learning to drive COVID-19 rapid drug repurposing
2020
·
Sarah Kolitz
, Jason Kim
, et al.
·
Journal for ImmunoTherapy of Cancer
·
3
PDF
449 Cyclic disruption of the mitogen-activated protein kinase (MAPK) pathway by the dual MEK inhibitor, IMM-6-415, enhances PD1 and CTLA4 checkpoint blockade in RAS mutant tumors
2022
·
Brett Hall
, Anna Travesa
, et al.
·
Journal for ImmunoTherapy of Cancer
·
2
PDF
Explanatory Chapter: Nucleic Acid Concentration Determination
2013
·
Sarah Kolitz
, Jon Lorsch
·
Methods in enzymology on CD-ROM/Methods in enzymology
·
2
Abstract 1873: Atebimetinib’s deep cyclic inhibition of MEK constrains MAPK-axis adaptive and acquired alterations in patients with RAS-mutant tumors.
2026
·
Jason S. Kim
, Jason Funt
, et al.
·
Cancer Research
·
1
Abstract P240: Benchmarking the novel dual-MEK inhibitor, IMM-1-104, head-to-head and in combination with sotorasib (AMG-510) in the MIA PaCa-2 (KRAS-G12C) pancreatic cancer xenograft model
2021
·
Peter J. King
, Amy E. Axel
, et al.
·
Molecular Cancer Therapeutics
·
1
664 Applying advanced data analysis to immunotherapy drug discovery for Uveal Melanoma
2020
·
Sarah Kolitz
, Yoonjeong Cha
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
PDF
Response to the Letter-to-the Editor by Cohen et al. concerning our eNeurologicalSci article, Melamed-Gal, et al. Physicochemical, biological, functional and toxicological characterization of the European follow-on glatiramer acetate product as compared with Copaxone. eNeurologicalSci 2018;12:19–30.https://doi.org/10.1016/j.ensci.2018.05.006
2018
·
Sigal Melamed-Gal
, Pippa Loupe
, et al.
·
eNeurologicalSci
·
1
PDF
Show more works
View as search
Works count:
66
Citation count:
1,027
H-index:
16
I10-index:
16
Year
Topic
Type
